Iovance Biotherapeutics, Inc. (IOVA): Shares Outstanding
411.94M
As of 2025-12-31
452.97M
As of 2026-06-30
+29.9%
3-year compound annual growth
+22.7%
5-year compound annual growth
+23.8%
10-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 411.94M | +35.0% | 2026-02-24, Balance as of period end |
| 2024-12-31 | 305.25M | +19.2% | 2026-02-24, Balance as of period end |
| 2023-12-31 | 256.14M | +36.4% | 2025-02-27, Balance as of period end |
| 2022-12-31 | 187.81M | +19.6% | 2024-02-28, Balance as of period end |
| 2021-12-31 | 157.00M | +6.2% | 2023-02-28, Balance as of period end |
| 2020-12-31 | 147.87M | +17.0% | 2022-02-24, Balance as of period end |
| 2019-12-31 | 126.41M | +2.4% | 2021-02-25, Balance as of period end |
| 2018-12-31 | 123.42M | +68.7% | 2020-02-25, Balance as of period end |
| 2017-12-31 | 73.16M | +17.5% | 2019-02-28, Balance as of period end |
| 2016-12-31 | 62.25M | +28.2% | 2018-03-12, Balance as of period end |
| 2015-12-31 | 48.55M | n/c | 2017-03-09, Balance as of period end |
| 2014-12-31 | 33.75M | +68.5% | 2016-03-11, Balance as of period end |
| 2013-12-31 | 20.02M | n/m | 2015-03-16, Balance as of period end |
| 2012-12-31 | 818.8K | -99.0% | 2014-03-28, Balance as of period end |
| 2011-12-31 | 77.99M | +5.9% | 2013-09-23, Balance as of period end |
| 2010-12-31 | 73.64M | n/a | 2012-03-30, Balance as of period end |